logo
‘A rose by any other name would smell as sweet’, or would it?
Umbilical cord blood graft enhancement strategies: has the time come to move these into the clinic?
Rescuing the neonatal brain from hypoxic injury with autologous cord blood
Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study
Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers
Mobilization of PBSC for allogeneic transplantation by the use of the G-CSF biosimilar XM02 in healthy donors
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Tandem high-dose chemotherapy and auto-SCT for malignant brain tumors in children under 3 years of age
Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients
A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1
Major ABO-incompatible BMT: isohemagglutinin reduction with plasma exchange is safe and avoids graft manipulation
Clinical effect of individualized parenteral nutrition vs conventional method in patients undergoing autologous hematopoietic SCT
Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT)
In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden
New-onset microalbuminuria following allogeneic myeloablative SCT is a sign of near-term decrease in renal function
Citrulline and albumin as biomarkers for gastrointestinal mucositis in recipients of hematopoietic SCT
Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study
Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT
Azacitidine in the treatment of extramedullary relapse of AML after allogeneic hematopoietic cell transplantation
Semi-ambulatory autologous peripheral blood SCT in 79 patients with multiple myeloma
Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia/lymphoma after umbilical cord blood transplantation
KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation
Oncogenic driver supersedes BM preparation as the critical determinant of leukemic outcome: a one day protocol for BM harvest, infection and transplantation
Remission of Crohn's disease after cord blood transplantation for leukocyte adhesion deficiency type 1
Yellow fever vaccine viremia following ablative BM suppression in AML
Pre-emptive antiviral therapy for active CMV infection in adult allo-SCT patients guided by plasma CMV DNAemia quantitation using a real-time PCR assay: clinical experience at a single center